Publication Name	World Journal of Clinical Cases
Manuscript ID	86973
Country	Japan

Received	2023-07-21 12:56
Peer-Review Started	2023-07-21 13:00
First Decision by Editorial Office Director	2023-09-13 03:26
Return for Revision	2023-09-13 03:26
Revised	2023-09-26 03:16
Publication Fee Transferred
Second Decision by Editor	2023-10-07 02:50
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2023-10-08 03:41
Articles in Press	2023-10-08 03:41
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-10-17 15:21
Publish the Manuscript Online	2023-10-25 08:49

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Chemistry, Organic
Manuscript Type	Case Report
Article Title	Diffuse large B-cell lymphoma successfully treated with amplified natural killer therapy alone: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Kenjiro Nagai, Syo Nagai, Yuji Okubo and Keisuke Teshigawara
ORCID	Author(s) ORCID Number Kenjiro Nagai http://orcid.org/0000-0002-7726-7403
Funding Agency and Grant Number
Corresponding Author	Kenjiro Nagai, MD, Chief Doctor, Department of Internal Medicine, Medical Corporation Ebino Centro Clinic, 1007-4 Uwae, Ebino 889-4304, Japan. ken701n427@gmail.com
Key Words	Diffuse large B-cell lymphoma; Natural killer cells; Immunostaining; Hodgkin's lymphoma; Older adult; Case report
Core Tip	The current patient was programmed death ligand 1 (PD-L1) positive, and the treatment was highly effective. Accordingly, amplified natural killer (ANK) therapy could be employed as a first-line treatment for malignant lymphoma based on the therapeutic efficacy and minimal side effects. Moreover, the PD-L1 positivity rate may serve as a biomarker for predicting the efficacy of ANK therapy.
Publish Date	2023-10-25 08:49
Citation	Nagai K, Nagai S, Okubo Y, Teshigawara K. Diffuse large B-cell lymphoma successfully treated with amplified natural killer therapy alone: A case report. World J Clin Cases 2023; 11(30): 7432-7439
URL	https://www.wjgnet.com/2307-8960/full/v11/i30/7432.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i30.7432

Full Article (PDF)	WJCC-11-7432-with-cover.pdf
Full Article (Word)	WJCC-11-7432.docx
CARE Checklist–2016	86973-CARE Checklist (2016).pdf
Manuscript File	86973_Auto_Edited-LJH-JLW.docx
Answering Reviewers	86973-Answering reviewers.pdf
Audio Core Tip	86973-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	86973-Conflict-of-interest statement.pdf
Copyright License Agreement	86973-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	86973-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	86973-Language certificate.pdf
Peer-review Report	86973-Peer-review(s).pdf
Scientific Misconduct Check	86973-Bing-Liu JH-2.png
Scientific Misconduct Check	86973-CrossCheck.png
Scientific Editor Work List	86973-Scientific editor work list.pdf
CrossCheck Report	86973-CrossCheck report.pdf